Omalza, Joessabeth .

HRN: 01-18-01  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2026
CEFUROXIME 500MG (TAB)
04/01/2026
04/07/2026
PO
500mg
Bid
Uti, Wbc (cbc) 22
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: